APOL1 and renal cell carcinoma: Additionally, APOL1 has been reported as a biomarker for renal diseases27, associated with autophagy and renal cell carcinoma, chronic kidney disease, and hypertensive nephrosclerosis28, heroin-associated nephropathy, and HIV-associated nephropathy29.